140 related articles for article (PubMed ID: 11881817)
1. Minor H antigens: genes and peptides.
Simpson E; Scott D; James E; Lombardi G; Cwynarski K; Dazzi F; Millrain JM; Dyson PJ
Eur J Immunogenet; 2001 Oct; 28(5):505-13. PubMed ID: 11881817
[TBL] [Abstract][Full Text] [Related]
2. Minor H antigens: genes and peptides.
Simpson E; Scott D; James E; Lombardi G; Cwynarski K; Dazzi F; Millrain M; Dyson PJ
Transpl Immunol; 2002 Aug; 10(2-3):115-23. PubMed ID: 12216941
[TBL] [Abstract][Full Text] [Related]
3. Minor transplantation antigens: mouse models for human host-versus-graft, graft-versus-host and graft-versus-leukemia reactions.
Simpson E
Arch Immunol Ther Exp (Warsz); 1998; 46(6):331-9. PubMed ID: 9883311
[TBL] [Abstract][Full Text] [Related]
4. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
5. Minor transplantation antigens: their role in shaping the T cell repertoire.
Simpson E; Tomonari K; Lovering E
Immunol Lett; 1989 Apr; 21(1):39-44. PubMed ID: 2656512
[TBL] [Abstract][Full Text] [Related]
6. Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens.
Fuchs KJ; Honders MW; van der Meijden ED; Adriaans AE; van der Lee DI; Pont MJ; Monajemi R; Kielbasa SM; 't Hoen PAC; van Bergen CAM; Falkenburg JHF; Griffioen M
Front Immunol; 2020; 11():659. PubMed ID: 32362897
[TBL] [Abstract][Full Text] [Related]
7. Minor histocompatibility antigens--targets of graft versus leukemia responses.
Riddell SR; Murata M; Bryant S; Warren EH
Int J Hematol; 2002 Aug; 76 Suppl 2():155-61. PubMed ID: 12430918
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation.
Gezinir E; Podlech J; Gergely KM; Becker S; Reddehase MJ; Lemmermann NAW
Front Cell Infect Microbiol; 2020; 10():279. PubMed ID: 32582572
[TBL] [Abstract][Full Text] [Related]
9. The molecular and functional characterization of a dominant minor H antigen, H60.
Malarkannan S; Shih PP; Eden PA; Horng T; Zuberi AR; Christianson G; Roopenian D; Shastri N
J Immunol; 1998 Oct; 161(7):3501-9. PubMed ID: 9759870
[TBL] [Abstract][Full Text] [Related]
10. Natural regulation of immunity to minor histocompatibility antigens.
Robertson NJ; Chai JG; Millrain M; Scott D; Hashim F; Manktelow E; Lemonnier F; Simpson E; Dyson J
J Immunol; 2007 Mar; 178(6):3558-65. PubMed ID: 17339452
[TBL] [Abstract][Full Text] [Related]
11. H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect.
Choi EY; Choi K; Nam G; Kim W; Chung M
Front Immunol; 2020; 11():1163. PubMed ID: 32587590
[TBL] [Abstract][Full Text] [Related]
12. Minor histocompatibility antigens: past, present, and future.
Spierings E
Tissue Antigens; 2014 Oct; 84(4):374-60. PubMed ID: 25262921
[TBL] [Abstract][Full Text] [Related]
13. Non-myeloablative transplants for malignant disease.
Storb RF; Champlin R; Riddell SR; Murata M; Bryant S; Warren EH
Hematology Am Soc Hematol Educ Program; 2001; ():375-91. PubMed ID: 11722994
[TBL] [Abstract][Full Text] [Related]
14. Minor histocompatibility antigen typing by DNA sequencing for clinical practice in hematopoietic stem-cell transplantation.
Spierings E; Goulmy E
Methods Mol Biol; 2012; 882():509-30. PubMed ID: 22665253
[TBL] [Abstract][Full Text] [Related]
15. Minor histocompatibility antigens as determinants for graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Turpeinen H; Ojala PJ; Ojala K; Miettinen M; Volin L; Partanen J
Int J Immunogenet; 2013 Dec; 40(6):495-501. PubMed ID: 23480177
[TBL] [Abstract][Full Text] [Related]
16. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens.
Dickinson AM; Wang XN; Sviland L; Vyth-Dreese FA; Jackson GH; Schumacher TN; Haanen JB; Mutis T; Goulmy E
Nat Med; 2002 Apr; 8(4):410-4. PubMed ID: 11927949
[TBL] [Abstract][Full Text] [Related]
17. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.
Laurin D; Hannani D; Pernollet M; Moine A; Plumas J; Bensa JC; Cahn JY; Garban F
Transfusion; 2010 Feb; 50(2):418-28. PubMed ID: 19843288
[TBL] [Abstract][Full Text] [Related]
18. Targeting alloreactive donor T-cells to hematopoietic system-restricted minor histocompatibility antigens to dissect graft-versus-leukemia effects from graft-versus-host disease after allogeneic stem cell transplantation.
Mutis T
Int J Hematol; 2003 Oct; 78(3):208-12. PubMed ID: 14604278
[TBL] [Abstract][Full Text] [Related]
19. Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
Ofran Y; Kim HT; Brusic V; Blake L; Mandrell M; Wu CJ; Sarantopoulos S; Bellucci R; Keskin DB; Soiffer RJ; Antin JH; Ritz J
Clin Cancer Res; 2010 Mar; 16(5):1642-51. PubMed ID: 20160060
[TBL] [Abstract][Full Text] [Related]
20. Few peptides dominate cytotoxic T lymphocyte responses to single and multiple minor histocompatibility antigens.
Yin L; Poirier G; Neth O; Hsuan JJ; Totty NF; Stauss HJ
Int Immunol; 1993 Sep; 5(9):1003-9. PubMed ID: 7694638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
